Error: Could not add to watchlist. X

Idenix Pharmaceuticals Inc

+ Watchlist
IDIX:US
Acquired
IDIX:US was acquired by MRK:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.10
Market Cap (USD)
-
Shares Outstanding (m)
151.504
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).
ADDRESS
60 Hampshire Street
Cambridge, MA 02139
United States
PHONE
1-617-995-9800
  • Douglas Mayers
    Exec VP/Chief Medical Officer
  • Daniella Beckman
    Senior VP/CFO/Treasurer
  • Paul J Fanning
    Senior VP:Human Resources
Show More